BRAINSTORM CELL THERAPEUTICS
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). NurOwn™, our proprietary, first-of-its-kind technology for the propagation and differentiation of autologous Mesenchymal Stem Cells (MSCs) into NeuroTrophic Factor (NTF)-secreting cells and their tran... splantation at or near the site of damage, offers the hope of conquering neurodegenerative diseases. We are currently conducting a Phase IIa ALS clinical trial with NurOwn at the Hadassah University Medical Center in Jerusalem. In this safety and preliminary efficacy trial, 12 patients will receive combined intramuscular and intrathecal administration of neuron cells in three cohorts with increasing doses. The study participants will be followed for three to six months after transplantation. The company also plans to begin a Phase II clinical trial in the USA in 2013, pending FDA approval. On February 2011, NurOwn was granted Orphan Drug designation by the FDA. Over 20 publications in leading scientific journals demonstrating neuron mechanism of action, pharmacology and in vivo efficacy have been published by the scientific team.
BRAINSTORM CELL THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2000-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.brainstorm-cell.com
Total Employee:
11+
Status:
Active
Contact:
+1 646 666 3188
Email Addresses:
[email protected]
Total Funding:
51.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Avobis Bio
Avobis Bio develops investigational implantable cell therapies to treat debilitating conditions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TNeuroPharma
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.
Current Employees Featured
Founder
Stock Details
Investors List
Israel Innovation Authority
Israel Innovation Authority investment in Grant - BrainStorm Cell Therapeutics
Abbhi Capital
Abbhi Capital investment in Post-IPO Equity - BrainStorm Cell Therapeutics
National Multiple Sclerosis Society (NMSS)
National Multiple Sclerosis Society (NMSS) investment in Grant - BrainStorm Cell Therapeutics
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - BrainStorm Cell Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - BrainStorm Cell Therapeutics
Brazilian Ministry of Health
Brazilian Ministry of Health investment in Grant - BrainStorm Cell Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-02 | Brainstorm Cell Therapeutics Names Setboun Chief Operating Officer |
Official Site Inspections
http://www.brainstorm-cell.com Semrush global rank: 6.44 M Semrush visits lastest month: 1.01 K
- Host name: 42.57.196.35.bc.googleusercontent.com
- IP address: 35.196.57.42
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
